Prophylaxis failure is associated with a specific Pneumocystis carinii genotype

Clin Infect Dis. 2001 Oct 1;33(7):1080-2. doi: 10.1086/322659. Epub 2001 Aug 22.

Abstract

To investigate the possible association between Pneumocystis carinii types and various clinical and demographic parameters, we used molecular typing to analyze 93 bronchoalveolar lavage specimens from patients with P. carinii pneumonia (PCP). Multivariate regression analysis revealed an association between being infected with a specific P. carinii genotype and receiving anti-PCP prophylaxis (odds ratio, 4.4; 95% confidence interval, 1.0-18.6; P=.05), although no association with a specific drug was detected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antifungal Agents / therapeutic use*
  • Bronchoalveolar Lavage Fluid / microbiology
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mycological Typing Techniques
  • Pneumocystis / classification*
  • Pneumocystis / genetics*
  • Pneumonia, Pneumocystis / microbiology*
  • Pneumonia, Pneumocystis / prevention & control*
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational
  • Treatment Failure

Substances

  • Antifungal Agents